Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results ; volume:3 ; number:1 ; day:6 ; month:2 ; year:2014 ; pages:1-8 ; date:12.2014
SpringerPlus ; 3, Heft 1 (6.2.2014), 1-8, 12.2014
- Creator
-
Fried, Georgeta
- Contributor
-
Moskovitz, Mor
SpringerLink (Online service)
- DOI
-
10.1186/2193-1801-3-71
- URN
-
urn:nbn:de:1111-201606107861
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fried, Georgeta
- Moskovitz, Mor
- SpringerLink (Online service)
Other Objects (12)
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
The impact of CBP expression in estrogen receptor-positive breast cancer
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer